This inventor holds 1 USPTO granted patent. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Peter JR Ebert
Introduction
Peter JR Ebert is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of T cell research. His work has implications for cancer treatment and immunotherapy.
Latest Patents
Peter JR Ebert holds a patent for "Determining WT-1-Specific T Cells and WT-1 Specific T Cell Receptors (TCRS)." This patent highlights his innovative approach to identifying specific T cells that can be utilized in targeted therapies.
Career Highlights
Ebert is currently associated with Adaptive Biotechnologies Corporation, a company known for its advancements in immune-driven medicine. His role at the company allows him to work on cutting-edge research that aims to improve patient outcomes through personalized medicine.
Collaborations
Some of his notable coworkers include Marcos E Milla and Mark Klinger. Their collaborative efforts contribute to the innovative environment at Adaptive Biotechnologies Corporation.
Conclusion
Peter JR Ebert's work exemplifies the intersection of innovation and biotechnology, showcasing the potential of targeted therapies in modern medicine. His contributions are paving the way for advancements in cancer treatment and immunotherapy.